Estudio y seguimiento durante un año de pacientes de nuestra área de salud en tratamiento con un fármaco hipotensor ocular tópico. Caractarísticas clínicas de los pacientes, capacidad diagnóstica del tomógrafo retiniano Heidelberg II y efectividad y seguridad de varios fármacos hipotensores oculares tópicos.

Abstract

Purpose: To investigate the diagnosis of the patients receiving monotherapy with an ocular hypotensive drug in our health area. Methods: Ninety six patients were recruited. Their treatment was interrupted and they were followed for 1 year with various tests that included visual field exploration and optic disk topography. The patients whose intraocular pressures were > 23 mm of Hg or that were diagnosed of having glaucoma were re-treated with timolol, latanoprost or brimonidine. Seventy patients completed the study and received a clinical diagnosis and a second diagnosis by the Moorfields regression analysis classification.Results: Only 31 patients (44.3%) needed re-treatment. Of the 39 patients (55.7%) that did not require re-treatment, 7 (10%) received a diagnosis of glaucoma suspicion and 32 patients (45.7%) were considered normal.Conclusion: Around 50% of the patients receiving monotherapy with an ocular hypotensive drug in our health area do not need the treatment.